INTRODUCTION
============

Hysterectomy is the second most common surgery women undergo.^[@B1]^ Annually, 600,000 hysterectomies are performed in the United States and account for \$5 billion USD in national health care spending.^[@B1],[@B2]^ Few data exist regarding preoperative risk factors and its association with postoperative outcomes.

In a 2002 meta-analysis of over 1.5 million patients who underwent gynecologic laparoscopic operations, the rate of complications ranged from 0.2% to 10.3%.^[@B3]^ A 2007 study by O\'Hanlan et al^[@B4]^ found a 9.8% complication rate in 830 cases of total laparoscopic hysterectomy (TLH). The complications included fever, hemorrhage, infection, wound dehiscence, voiding dysfunction, urological injuries, intestinal issues, deep venous thrombosis, anesthesia-related events, and conversion to laparotomy.^[@B3],[@B4]^ Minimally invasive methods including vaginal hysterectomies and laparoscopic techniques have been associated with decreased blood loss, shorter hospital stay, and decreased infections when compared to abdominal hysterectomies.^[@B5][@B6][@B7]^ Despite the evidence in favor of minimally invasive hysterectomy, abdominal hysterectomies account for 45%--50% of hysterectomies.^[@B8][@B9][@B10]^ Minimally invasive hysterectomy has been on the rise in recent years with some limitations of implementation being cost, surgeon training, hospital technology, clinical factors, and patient preference.^[@B2],[@B11]^

Chronic obstructive pulmonary disease (COPD) is the third leading cause of disability and mortality, affecting approximately 600 million worldwide.^[@B12]^ In the United States, prevalence of COPD is around 7.6% in women.^[@B13]^ The prevalence and mortality rate of COPD in women have doubled during the past 30 years in industrialized countries, which is in contrast to the plateau in COPD-related mortality for men.^[@B13]^ Women may be more susceptible to the negative effects of tobacco smoke.^[@B14],[@B15]^

By the age of 60, an estimated 33% of women will have a hysterectomy and the increasing prevalence of COPD reinforces the need for data on their relationship.^[@B13],[@B16]^ This study aims to examine the following questions: 1) what demographics and comorbidities are most likely to present concurrently in patients with COPD? 2) Are patients with COPD undergoing laparoscopic hysterectomy at increased risk for development of postoperative complications within 30 days?

METHODS
=======

The American College of Surgeons National Surgery Quality Improvement Program is a national database comprised of data from 600 hospitals with the goal of optimizing quality of surgical care. This paper used American Medical Association Current Procedural Terminology (CPT) codes to identify patients in the database who underwent TLH (58570, 58571, 58572, 58573), laparoscopically assisted vaginal hysterectomy (58550, 58552, 58553, 58554), and laparoscopic supracervical hysterectomy (58541, 58542, 58543, 58544). Once patients were identified through CPT codes, information regarding their demographics (including patient race and age), medical comorbidities, preoperative factors, and postoperative complications within 30 days of hysterectomy were collected.

Comorbidity data collected included current use of antihypertensive medication, renal failure, need for dialysis, steroid use, recent unexplained weight loss, bleeding disorders, preoperative transfusion, malignancy as indication for hysterectomy, and uterine size \> 250 g. Preoperative factors associated with increased risk of postoperative complications, including smoking status, diabetes mellitus status, body mass index, dyspnea status, American Society of Anesthesiologists (ASA) class, type of anesthesia used, and preoperative functional status, were also recorded.

The 30-day postoperative complications included in this analysis were surgical-site wound infection, deep wound infection, organ or space infections, wound dehiscence, pneumonia, reintubation, pulmonary embolism, failure to wean off ventilator within 48 hours of hysterectomy, renal failure, renal insufficiency, urinary tract infection, stroke, cardiac arrest, myocardial infarction, deep vein thrombosis, sepsis, septic shock, and all-cause death. Thirty-day postoperative outcomes, including extended length of stay (hospital stay \> 2 d) and unplanned return to operating room (OR), were also analyzed.

Univariate analysis was performed using χ^2^ test, Fisher\'s exact test, and one-way analysis of variance (ANOVA). Age and body mass index were analyzed by χ^2^ test, Fisher\'s exact test, and one-way ANOVA; however, for multivariate analysis, if both the categorical analysis and one-way ANOVA tests resulted in statistical significance, the continuous variable was used instead of the categorical variable. To determine independent risk factors for returning to the OR and extended length of stay (\>2 d), risk factors with *P* \< .2 in univariate analysis were included in multivariate analysis. In addition to including the risk factors identified through univariate analysis, COPD was considered a risk factor in multivariate analysis. Multivariate regression analysis was performed using binary logistic regression for return to the OR, extended length of stay (\> 2 days) (LOS) using a forward stepwise approach; Poisson log-linear regression analysis was performed on 30-day postoperative complications using a forward stepwise approach. Results of multivariate analyses were reported as odds ratios with 95% confidence intervals. Those with a *P* \< .05 were considered statistically significant. Statistical analysis was conducted using Statistical Package for the Social Sciences (SPSS Version 22, Armonk, NY, USA).

RESULTS
=======

Demographics
------------

A total of 100,518 patients underwent laparoscopic hysterectomy and met inclusion criteria for this study. A total of 1,130 patients had COPD (1.1%) and 99,388 did not have a diagnosis of COPD. Patients with COPD were on average more likely to be older (*P* ≤ .001), have a higher body mass index (*P* ≤ .001), have diabetes (*P* ≤ .001), have a higher ASA class (*P* ≤ .001), be a smoker, have moderate exertional dyspnea (*P* ≤ .001), and be less functionally independent (*P* ≤ .001) than those without a COPD diagnosis (**[Tables 1](#T1){ref-type="table"}** and **[2](#T2){ref-type="table"}**).

###### 

Demographics and Clinical Characteristics of 100,518 Patients who Underwent Laparoscopic Hysterectomy

  Demographics                              No COPD (N = 99,388)   Yes COPD (N = 1,130)   *P*-Value          
  ----------------------------------------- ---------------------- ---------------------- ----------- ------ ------------
  Race                                                                                                       **\<.001**
      White                                 71,813                 72.3                   898         79.5   
      Black or African American             12,963                 13.0                   129         11.4   
      Hispanic                              9,842                  9.9                    87          7.7    
      American Indian or Alaska Native      145                    0.1                    3           0.3    
      Asian                                 3,557                  3.6                    2           0.2    
      Native Hawaiian or Pacific Islander   641                    0.6                    8           0.7    
  Anesthesia                                                                                                 .359
      General                               99,255                 99.9                   1,128       99.8   
      Regional                              106                    0.1                    1           0.1    
      MAC/IV sedation                       27                     0.0                    1           0.1    
  Diabetes                                                                                                   **\<.001**
      No diabetes                           90,565                 91.1                   878         77.7   
      Noninsulin-dependent DM               6,483                  6.5                    152         13.5   
      Insulin-dependent DM                  2,489                  2.5                    100         8.8    
  ASA class                                                                                                  **\<.001**
      1 or 2                                75,360                 75.8                   310         27.4   
      3 or 4                                24,301                 24.5                   820         72.6   
  Smoke                                     16,546                 16.6                   521         46.1   **\<.001**
  Dyspnea                                                                                                    **\<.001**
      No dyspnea                            96,727                 97.3                   799         70.7   
      Moderate exertion                     2,585                  2.6                    310         27.4   
      At rest                               76                     0.1                    21          1.9    
  Functional status pre-op                                                                                   **\<.001**
      Independent                           99,076                 99.7                   1,108       98.1   
      Partially dependent                   274                    0.3                    18          1.6    
      Totally dependent                     38                     0.0                    4           0.4    

ASA, American Society of Anesthesiologists class; COPD, Chronic obstructive pulmonary disease; DM, diabetes mellitus; MAC/IV, monitored anesthesia care/intravenous.

Bolding indicates significance *P* \< .05.

###### 

Demographics of 100,518 Patients who Underwent Laparoscopic Hysterectomy

  Demographics               No COPD (N = 99,388)   Yes COPD (N = 1,130)   *P*-Value   No COPD, Mean   Yes COPD, Mean   ANOVA (*P*-Value)                    
  -------------------------- ---------------------- ---------------------- ----------- --------------- ---------------- ------------------- ---------------- ------------
  Age, years                                                                                           **\<.001**       48.170 ± 11.15      57.830 ± 12.73   **\<.001**
      18--30                 3,308                  3.3                    7           0.6                                                                   
      31--40                 20,933                 21.1                   91          8.1                                                                   
      41--50                 40,330                 40.6                   289         25.6                                                                  
      51--60                 19,127                 19.2                   295         26.1                                                                  
      61+                    15,690                 15.8                   448         39.6                                                                  
  BMI Class, kg/m^2^                                                                                   **\<.001**       30.743 ± 8.10       34.254 ± 10.47   **\<.001**
      Underweight (\<18.5)   795                    0.8                    17          1.5                                                                   
      Normal (18.5--24.9)    22,766                 22.9                   201         17.8                                                                  
      Non-obese (25--30)     27,438                 27.6                   238         21.1                                                                  
      Obese I (30--35)       21,264                 21.4                   217         19.2                                                                  
      Obese II (35--40)      27,125                 27.3                   457         40.4                                                                  
      Obese 3 (\>=40)                               0.0                                0.0                                                                   

BMI, body mass index; COPD, chronic obstructive pulmonary disease.

Bolding indicates significance *P* \< .05.

Comorbidities
-------------

Patients with COPD had more preoperative comorbidities than patients without COPD. Comorbidities included cardiac comorbidity (*P* \< .001), steroid use (*P* \< .001), weight loss (*P* = .003), bleeding disorder (*P* \< .001), gynecologic malignancy (*P* \< .001), uterine weight \>250 g (*P* \< .001), or disseminated cancer (*P* = .002). Renal failure, dialysis requirement, transfusion, chemotherapy, and pregnancy were not found to be significantly different between groups (**[Table 3](#T3){ref-type="table"}**).

###### 

Preoperative Comorbidities of 100,518 Patients who Underwent Laparoscopic Hysterectomy

  Comorbidities                                          No COPD (N = 99,388)   COPD (N = 1,130)   *P*-Value          
  ------------------------------------------------------ ---------------------- ------------------ ----------- ------ ------------
  Cardiac comorbidity[\*](#TF3-1){ref-type="table-fn"}   28,457                 28.6               646         57.2   **\<.001**
  Renal failure                                          12                     0.0                0           0.0    .712
  Dialysis                                               129                    0.1                4           0.4    **.039**
  Steroid use                                            1,448                  1.5                69          6.1    **\<.001**
  Weight loss                                            162                    0.2                6           0.5    **.003**
  Bleeding disorder                                      932                    0.9                45          4.0    **\<0001**
  Transfusion                                            366                    0.4                4           0.4    .937
  Chemotherapy                                           34                     0.0                0           0.0    .518
  Pregnancy                                              9,610                  9.7                109         9.6    .379
  Uterine weight \>250 g                                 12,821                 12.9               93          3.5    **\<.001**
  Malignancy                                             16,256                 16.3               332         29.3   **\<.001**
  Disseminated cancer                                    551                    0.6                14          1.2    **.002**

COPD, chronic obstructive pulmonary disease.

Bolding indicates significance *P* \< .05.

Cardiac comorbidity was recorded as whether the patient was on hypertensive medications or not.

Complications
-------------

The patients who underwent hysterectomy with diagnosed COPD had higher rates of postoperative complications (*P* \< .001). Patients with COPD had a higher frequency of at least one complication, 121 (14.7%), compared with patients without COPD (5,487 \[5.5%\]) (**[Table 4](#T4){ref-type="table"}**). The patients with COPD had higher rates of superficial surgical site infection (*P* = .004), pneumonia (*P* \< .001), reintubation (*P* \< .001), renal insufficiency (*P* \< .020), renal failure (*P* = .004), sepsis (*P* = .018), and all-cause death (*P* = .015). The multivariate analysis showed that COPD is an independent risk factor for two postoperative complications (**[Table 5](#T5){ref-type="table"}**). Patients with COPD were 4.1 times more likely to develop pneumonia (95% CI, 2.222--7.519; *P* \< .001), and 4.3 times more likely to need unplanned reintubation (95% CI, 2.387--9.737; *P* \< .001).

###### 

Postoperative Complications and Outcomes of 100, 518 Patients who Underwent :Laparoscopic Hysterectomy

  Complications                         No COPD (N = 99,388)   COPD (N = 1,130)   *P*-Value          
  ------------------------------------- ---------------------- ------------------ ----------- ------ -------------
  Any complication                      5,487                  5.5                121         14.7   **\<.001**
      Superficial surgical site wound   804                    0.8                18          2.2    **.004**
      Deep wound infection              171                    0.2                3           0.4    .146
      Organ/space infection             904                    0.9                13          1.6    .428
      Wound dehiscence                  213                    0.2                5           0.6    .101
      Pneumonia                         120                    0.1                13          1.6    **\<.001**
      Re-intubate                       89                     0.1                14          1.7    **\<.001**
      Pulmonary embolism                214                    0.2                3           0.4    .718
      Fail to wean \>48 hours           46                     0.0                2           0.2    .102
      Renal insufficiency               48                     0.0                3           0.4    **.020**
      Renal failure                     18                     0.0                1           0.1    .087
      Urinary tract infection           2,200                  2.2                28          3.4    .548
      Stroke                            25                     0.0                1           0.1    .255
      Peripheral nerve injury           11                     0.0                0           0.0    1.000
      Cardiac arrest                    21                     0.0                0           0.0    1.000
      Myocardial infarction             27                     0.0                1           0.1    .271
      Deep vein thrombosis              136                    0.1                1           0.1    .744
      Sepsis                            338                    0.3                9           1.1    **.018**
      Septic shock                      59                     0.1                3           0.4    0.033
      Death                             43                     0.0                3           0.4    **0.015**
  Other outcomes                                                                                     
      Extended LOS (\>2 days)           3,292                  3.3                109         13.3   **\<0.001**
      Return to OR                      1,331                  1.3                19          2.3    0.361

Bolding indicates significance *P* \< 0.05.

COPD, chronic obstructive pulmonary disease; LOS, length of stay; OR, operating room.

###### 

Multivariate Analysis to Determine if COPD is an Independent Risk Factor for Post-operative Complications in 100, 518 Patients

  Postop Complication        *P*-Value    Odds Ratio   95% CI   
  -------------------------- ------------ ------------ -------- -------
  Superficial infection      .025         1.684        1.067    2.652
  Pneumonia                  **\<.001**   4.098        2.222    7.519
  Re-intubate                **\<.001**   4.348        2.387    7.937
  Renal insufficiency        .09          2.618        0.861    7.937
  Sepsis                     .093         1.770        0.910    3.448
  Death                      .667         1.319        0.372    4.673
  Extended LOS (\> 2 days)   **\<.001**   1.739        1.414    2.137

Bolding indicates significance *P* \< .05.

CI, confidence interval; LOS, length of stay.

Length of Stay/Return to the OR
-------------------------------

Univariate analysis found 109 (13.3%) patients with COPD and 3,292 (3.3%) patients without COPD required an extended LOS (\>2 days) (**[Table 4](#T4){ref-type="table"}**). In addition, multivariate analysis indicates COPD is an independent risk factor for extended LOS (OR, 1.739; 95% CI, 1.414--2.137; *P* \< .001) (**[Table 5](#T5){ref-type="table"}**). There was no significant difference in return to the OR based upon COPD status (**[Table 4](#T4){ref-type="table"}**).

DISCUSSION
==========

There is limited research on the impact of COPD on gynecologic surgery outcomes. Often, COPD is studied in relationship to pulmonary complications, but this study explores the implications of the disease on a wide range of outcomes following TLH. To our knowledge, this is the first study to establish a clear relationship between COPD and various postoperative complications following TLH. Pulmonary complications are among the most common postoperative complications associated with morbidity and mortality for all surgical procedures.^[@B17]^ Currently, there is a 1% occurrence of pulmonary complications for all patients in TLH.^[@B18]^ Our data analysis found COPD was an independent risk factor for pneumonia and unplanned reintubation. Patients with COPD were 4.6 times more likely to develop pneumonia (*P* \< .001) and 4.5 times more likely to need reintubation (*P* \< .001).

COPD has been shown to increase the overall complication rate in other surgical settings including general, cardiac, and thoracic.^[@B19]^ Patients who underwent laparoscopic hysterectomy with diagnosed COPD had higher rates of postoperative complications (*P* \< .001). Univariate analysis showed patients with COPD were nearly 3 times more likely to suffer from an all-cause complication than those without COPD. A 2012 study by Jennings et al^[@B20]^ found COPD to be a significant risk factor for readmission within 30 days of laparoscopic hysterectomy. The group with COPD had a readmission rate of 8.5% versus a readmission rate of 3.1% in the group without COPD (*P* = .02).^[@B20]^ In our study, COPD was demonstrated to be an independent risk factor for extended LOS (*P* \< .001). One retrospective study of pulmonary complications following gynecologic procedures found a significantly longer length of stay (1.75 days) associated with pulmonary complications.^[@B21]^

The indications for hysterectomy in 80% of cases are for benign pathology but impact of disease on patients can range from minor discomfort to debilitating pain.^[@B1]^ Assessing the risk and benefits for COPD patients is complicated due to variability in indication for hysterectomy and the elevated risk of postoperative complication, highlighting the importance of shared decision making between patient and gynecologist. The less invasive TLH approach to hysterectomy has been associated with decreased length of stay, morbidity, and infection over the open approach.^[@B5][@B6][@B7]^ Patients with COPD when possible should undergo minimally invasive hysterectomy to decrease the combined risk associated with COPD and open surgery, which includes increased length of stay, morbidity, and infection. In the setting of elective operation, measures to medically optimize patients should be implemented. These measures include identifications of COPD by thorough history taking, and referral to pulmonologist for patient with extensive risk factors or suspicious signs and symptoms. Pulmonary specialists use the 2017 The Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria to stratify disease severity and make treatment decisions. Measures to reduce exacerbations and worsening of disease including nonpharmacologic and pharmacologic approaches.^[@B22],[@B23]^ Nonpharmacologic measures include patient education on smoking cessation, pulmonary rehabilitation, exercise, and immunizations, including annual influenza and pneumococcal vaccines. Pharmacologic approaches include long- and short-acting bronchodilators, long-acting muscarinic antagonists, and inhaled corticosteroids.^[@B22],[@B23]^

Beyond the preoperative setting to the OR, the American Society of Anesthesiologists uses a physical status classification of 1 to 6 to classify patients\' operative risk based on general health. A diagnosis of COPD is categorized by this system as a class 3 or 4, indicating severe systemic illness. Depending on disease control, COPD is classified as 3 for nonlife-threatening or 4 for constant threat to life.^[@B24]^ Further risk-modifying measures include considering the mode of anesthesia delivery. Studies suggest the use of regional anesthesia instead of general anesthesia in COPD patients has been associated with a decrease in the incidence of pulmonary complications.^[@B25],[@B26]^ Regional anesthesia is not generally applied for laparoscopic surgery but is feasible for vaginal hysterectomy.^[@B27]^ The optimal surgical approach for the pathology should be carefully considered and must be weighed against the optimal anesthesia for that approach. Future studies comparing surgical approach for hysterectomy as well as type of anesthesia for patients with COPD with would be beneficial.

Among the limitations of this study is the retrospective design and inherent selection bias. In our study patients with COPD were more likely to have comorbidities and surgical risk factors than the group without COPD. In addition, complications rates are only measured up to 30 days following operation. Furthermore, our study did not stratify the severity or stage of COPD in patients. Lastly, the Centers for Disease Control (CDC) projects that COPD may be underdiagnosed and, therefore, undertreated.^[@B28]^ Based on the findings of this study, the identification and treatment of COPD may alter the discrepant outcomes of patients with COPD. Despite these limitations, the current study identifies significant associations and has a large sample size with isolation of COPD as a risk factor for increased postoperative complications. These results have implications for patient outcomes and care. Future studies stratifying severity of COPD undergoing TLH can confirm whether optimizing management will attenuate the difference in outcomes between patients with COPD and those without. The identification of known risk factors of COPD will allow providers to predict and optimize treatment in the preoperative setting to mitigate potential postoperative complications.

CONCLUSION
==========

We used the National Surgery Quality Improvement Program database, including data from 100,518 patients, to understand the relationship of patients with COPD who underwent laparoscopic hysterectomies compared to patients without COPD. Patients with COPD had a greater risk of developing postoperative complications including pneumonia, unplanned reintubation, renal insufficiency, and sepsis. COPD was identified as an independent risk factor for the development of pneumonia, need for reintubation, and extended length of hospital stay. Gynecologists should take into consideration the COPD status of patients when assessing preoperative risk and refer to pulmonary specialist if needed for medical optimization. When possible, patients with COPD should be offered a minimally invasive hysterectomy to reduce risk of postoperative complications. This information will allow physicians to make better-informed clinical decisions on COPD patients undergoing hysterectomy.
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